Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hong, Sandy
Limit-JIA, NCT03841357: Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA	Completed	3	121	US	Abatacept Injection, Orencia, Usual Care	Duke University	Juvenile Idiopathic Arthritis	01/25	01/25
NCT02418442: Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry	Recruiting	N/A	20000	Europe, Canada, US, RoW		Duke University, Childhood Arthritis and Rheumatology Research Alliance	Rheumatic Joint Disease	06/28	12/28
Correll, Colleen
Limit-JIA, NCT03841357: Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA	Completed	3	121	US	Abatacept Injection, Orencia, Usual Care	Duke University	Juvenile Idiopathic Arthritis	01/25	01/25
BACK-OFF JSpA, NCT04891640: Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis	Recruiting	N/A	198	Canada, US	Standard TNFi Therapy, TNFi fixed longer dosing intervals, Stop TNFi treatment	Children's Hospital of Philadelphia, Patient-Centered Outcomes Research Institute	Juvenile Spondyloarthritis	07/26	07/27
NCT02418442: Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry	Recruiting	N/A	20000	Europe, Canada, US, RoW		Duke University, Childhood Arthritis and Rheumatology Research Alliance	Rheumatic Joint Disease	06/28	12/28